Hongxia Cheng

898 total citations
51 papers, 676 citations indexed

About

Hongxia Cheng is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Hongxia Cheng has authored 51 papers receiving a total of 676 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 15 papers in Oncology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Hongxia Cheng's work include Drug Transport and Resistance Mechanisms (6 papers), Cancer-related gene regulation (4 papers) and Epigenetics and DNA Methylation (4 papers). Hongxia Cheng is often cited by papers focused on Drug Transport and Resistance Mechanisms (6 papers), Cancer-related gene regulation (4 papers) and Epigenetics and DNA Methylation (4 papers). Hongxia Cheng collaborates with scholars based in China, Ethiopia and United States. Hongxia Cheng's co-authors include Peng Su, Gengyin Zhou, Yejun Qin, Xiaofang Zhang, Guolin Zou, Lei Xiang, Xiaojuan Wu, Weiwei Li, Hui Zhang and Wei Bao and has published in prestigious journals such as Brain Research, International Journal of Molecular Sciences and Advanced Science.

In The Last Decade

Hongxia Cheng

48 papers receiving 667 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hongxia Cheng China 16 406 164 136 71 53 51 676
Ying Jin China 15 379 0.9× 196 1.2× 154 1.1× 57 0.8× 60 1.1× 37 706
Arijit Bhowmik India 11 381 0.9× 147 0.9× 108 0.8× 64 0.9× 31 0.6× 27 686
Wei Hang China 8 360 0.9× 194 1.2× 114 0.8× 112 1.6× 30 0.6× 30 660
N. Patrick McCabe United States 13 318 0.8× 204 1.2× 110 0.8× 97 1.4× 44 0.8× 17 753
Yingying Miao China 14 266 0.7× 108 0.7× 100 0.7× 108 1.5× 31 0.6× 34 595
Suvajit Sen United States 17 354 0.9× 82 0.5× 106 0.8× 81 1.1× 24 0.5× 29 744
Bingchen Han United States 12 434 1.1× 342 2.1× 180 1.3× 82 1.2× 31 0.6× 16 767
Chieh‐Lin Wu Taiwan 14 358 0.9× 97 0.6× 77 0.6× 47 0.7× 56 1.1× 17 703
Sifan Yu China 18 519 1.3× 230 1.4× 145 1.1× 149 2.1× 24 0.5× 56 878

Countries citing papers authored by Hongxia Cheng

Since Specialization
Citations

This map shows the geographic impact of Hongxia Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongxia Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongxia Cheng more than expected).

Fields of papers citing papers by Hongxia Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongxia Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongxia Cheng. The network helps show where Hongxia Cheng may publish in the future.

Co-authorship network of co-authors of Hongxia Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Hongxia Cheng. A scholar is included among the top collaborators of Hongxia Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongxia Cheng. Hongxia Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Anqi, et al.. (2025). Urolithin A alleviates radiation pneumonitis by activating PINK1/PRKN-mediated Mitophagy. International Immunopharmacology. 156. 114671–114671.
2.
Meng, Lu, et al.. (2025). Mechanisms Underlying Radioresistance and Reversal Strategies in Non-Small Cell Lung Cancer. International Journal of Molecular Sciences. 26(14). 6559–6559. 1 indexed citations
3.
Cheng, Hongxia, Jiacheng Yin, Yuansheng Zheng, et al.. (2025). NDRG1‐Driven Lactate Accumulation Promotes Lung Adenocarcinoma Progression Through the Induction of an Immunosuppressive Microenvironment. Advanced Science. 12(33). e01238–e01238. 4 indexed citations
4.
Chen, Kaige, Linxiang Wang, Feng‐Yun Cui, et al.. (2024). CT-based radiomics nomogram to predict proliferative hepatocellular carcinoma and explore the tumor microenvironment. Journal of Translational Medicine. 22(1). 683–683. 11 indexed citations
5.
Cheng, Hongxia, Yilan Huang, Miaomiao Li, et al.. (2024). HSP90a promotes the resistance to oxaliplatin in HCC through regulating IDH1-induced cell competition. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1871(5). 119680–119680. 1 indexed citations
6.
Ma, Yuhan, et al.. (2024). Advanced gene therapy system for the treatment of solid tumour: A review. Materials Today Bio. 27. 101138–101138. 14 indexed citations
7.
Zhang, Linlin, et al.. (2024). The research focus and frontiers in surgical treatment of essential tremor. Frontiers in Neurology. 15. 1499652–1499652. 1 indexed citations
8.
Fu, Min, et al.. (2022). Total glucosides of peony induce fibroblast-like synovial apoptosis, and ameliorate cartilage injury via blocking the NF-κB/STAT3 pathway. Annals of Translational Medicine. 10(2). 51–51. 9 indexed citations
9.
Cheng, Hongxia, Dongmei Gao, Kangkang Yu, et al.. (2022). Nucleotide sugar transporter SLC35A2 is involved in promoting hepatocellular carcinoma metastasis by regulating cellular glycosylation. Cellular Oncology. 46(2). 283–297. 15 indexed citations
10.
Cheng, Hongxia, et al.. (2021). Fertility-sparing surgeries without adjuvant therapy through term pregnancies in a patient with low-grade endometrial stromal sarcoma: A case report. World Journal of Clinical Cases. 9(4). 983–991. 3 indexed citations
11.
Ji, Yuan, Fahad Shabbir Ahmed, Austin McHenry, et al.. (2021). High Counts of CD68+ and CD163+ Macrophages in Mantle Cell Lymphoma Are Associated With Inferior Prognosis. Frontiers in Oncology. 11. 701492–701492. 6 indexed citations
12.
13.
Yao, Zhigang, Fang Hua, Hongxia Cheng, et al.. (2017). LBH589 Inhibits Glioblastoma Growth and Angiogenesis Through Suppression of HIF-1α Expression. Journal of Neuropathology & Experimental Neurology. 76(12). 1000–1007. 33 indexed citations
14.
Zong, Yuanyuan, Pin Yü, Hongxia Cheng, et al.. (2015). miR-29c regulates NAV3 protein expression in a transgenic mouse model of Alzheimer׳s disease. Brain Research. 1624. 95–102. 40 indexed citations
15.
Cheng, Hongxia, Yejun Qin, Hui Fan, et al.. (2013). Overexpression of CARM1 in breast cancer is correlated with poorly characterized clinicopathologic parameters and molecular subtypes. Diagnostic Pathology. 8(1). 129–129. 62 indexed citations
16.
Wang, Weiping, Lei Chen, Qingmei Liu, et al.. (2012). Activation of transcriptional activity of HSE by a novel mouse zinc finger protein ZNFD specifically expressed in testis. Molecular and Cellular Biochemistry. 363(1-2). 409–417. 2 indexed citations
17.
Cheng, Hongxia, et al.. (2011). Studies on the interaction between docetaxel and human hemoglobin by spectroscopic analysis and molecular docking. Journal of Photochemistry and Photobiology B Biology. 105(2). 126–132. 44 indexed citations
18.
Cheng, Hongxia, Hui Liang, Yejun Qin, & Ying Liu. (2011). Nuclear beta-catenin overexpression in metastatic sentinel lymph node is associated with synchronous liver metastasis in colorectal cancer. Diagnostic Pathology. 6(1). 109–109. 17 indexed citations
19.
Zhang, Xinying, Fengqin Liu, Haiyan Liu, et al.. (2011). Urinary trypsin inhibitor attenuates lipopolysaccharide-induced acute lung injury by blocking the activation of p38 mitogen-activated protein kinase. Inflammation Research. 60(6). 569–575. 20 indexed citations
20.
Liu, Songtao, et al.. (2010). The clinical application value of PET/CT in adenocarcinoma with bronchioloalveolar carcinoma features. Annals of Nuclear Medicine. 24(7). 541–547. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026